Foundayo (Orforglipron) 36 mg Capsules – Oral GLP-1 Weight Management Support

Product Overview

Foundayo contains Orforglipron, an oral GLP-1 receptor agonist designed to support weight management in adults with obesity or overweight individuals with at least one weight-related health condition. Taken once daily, Foundayo works by helping regulate appetite and food intake as part of a comprehensive weight management plan that includes a balanced diet and regular physical activity.

Key Benefits

• Once-Daily Oral Capsule
  Convenient capsule format designed for daily use without injections.

• Supports Appetite Management
  Helps regulate appetite and food intake as part of a medically supervised weight management program.

• For Adults Managing Weight
  Suitable for adults with obesity or overweight with associated weight-related health conditions, when prescribed by a healthcare professional.

• Designed for Long-Term Weight Management
  Intended to be used alongside healthy lifestyle changes for sustainable weight management support.

Who Is Foundayo For?

Foundayo may be prescribed for adults who:

• Have obesity, or

• Are overweight with at least one obesity-related health condition

Treatment should be combined with a healthy diet and regular physical activity under medical supervision.

How To Use

• Take one capsule once daily as directed by your healthcare provider.

• Can be taken at any time of the day, with or without food.

• Swallow the capsule whole with water.

• Do not open, crush, break, or chew the capsule.

• Do not exceed one capsule per day.

Dosage Information

The recommended starting dose is:

• 1 mg once daily

Based on individual response and medical advice, the dose may be gradually increased after appropriate intervals:

• 3 mg

• 6 mg

• 12 mg

• 24 mg

• 36 mg (maximum daily dose)

Dose adjustments should only be made under the guidance of a healthcare professional.

Important Safety Information

Consult your doctor before using Foundayo, especially if you have:

• A history of pancreatitis

• Severe gastrointestinal conditions

• Liver-related health concerns

Foundayo is not recommended for:

• Children under 18 years of age

• Use during pregnancy or breastfeeding

• Individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Effective contraception is recommended during treatment.

Possible Side Effects

The most commonly reported side effects may include gastrointestinal symptoms such as:

• Nausea

• Vomiting

• Diarrhea

These effects are generally more common during dose increases and may reduce over time.

Drug Interactions

Inform your healthcare provider about all medicines you are taking.

Certain medications, including strong CYP3A4 inhibitors or inducers, may require dose adjustments or alternative treatment approaches.

Storage Instructions

• Store at or below 30°C.

• Keep in the original packaging.

• Protect from light.

• Keep out of reach of children.

Product Details

• Brand: Foundayo

• Active Ingredient: Orforglipron

• Strength: 36 mg

• Form: Oral Capsules

• Quantity: 30 Capsules

Medical Disclaimer:
Foundayo should only be used under medical supervision. Consult your doctor or pharmacist before starting treatment to determine if this medication is suitable for you.